Drug-induced autoimmune hemolytic anemia
| Drug-induced autoimmune hemolytic anemia | |
| ICD-10 | D59.0 |
|---|---|
| ICD-9 | 283 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Drug-induced autoimmune hemolytic anaemia is a form of hemolytic anaemia.
Penicillin in high doses can induce immune mediated hemolysis[1] via the hapten mechanism in which antibodies are targeted against the combination of penicillin in association with red blood cells. Complement is activated by the attached antibody leading to the removal of red blood cells by the spleen.
The drug itself can be targeted by the immune system, e.g. by IgE in a Type I hypersensitivity reaction to penicillin, rarely leading to anaphylaxis.
References
- ↑ Stroncek D, Procter JL, Johnson J (2000). <67::AID-AJH12>3.0.CO;2-Z "Drug-induced hemolysis: cefotetan-dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction". Am. J. Hematol. 64 (1): 67–70. PMID 10815791. Unknown parameter
|month=ignored (help)